Systemic sclerosis increases the risks of deep vein thrombosis and pulmonary thromboembolism: A nationwide cohort study

Rheumatology (United Kingdom)

Volumn 53, Issue 9, 2014, Pages 1639-1645

  Chung, Wei Sheng ^a,b   Lin, Cheng Li ^c,d   Sung, Fung Chang ^c,d   Hsu, Wu Huei ^b   Yang, Wen Ta ^a   Lu, Chuan Chin ^a   Kao, Chia Hung ^b,c  

^a National Taichung University   (China)

^b CHINA MEDICAL UNIVERSITY   (Taiwan)

^c CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^d CHINA MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Deep vein thrombosis; Nationwide cohort study; Pulmonary thromboembolism; Systemic sclerosis

Indexed keywords

ADULT; AGED; ARTICLE; CEREBROVASCULAR DISEASE; COHORT ANALYSIS; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; DIABETES MELLITUS; FEMALE; HEART ATRIUM FIBRILLATION; HEART FAILURE; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; LEG FRACTURE; LONGITUDINAL STUDY; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; MALIGNANT NEOPLASTIC DISEASE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PULMONARY HYPERTENSION; RETROSPECTIVE STUDY; SYSTEMIC SCLEROSIS; TAIWAN;

EID: 84906833126     PISSN: 14620324     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/keu133     Document Type: Article

References (30)

1. Atzeni F, Bardoni A, Cutolo M et al. Localized and systemic forms of scleroderma in adults and children. Clin Exp Rheumatol 2006;24(Suppl 40):S36-45.
2. Gabrielli A, Avvedimento EV, Krieg T. Scleroderma. N Engl J Med 2009;360:1989-2003.
3. Chifflot H, Fautrel B, Sordet C, Chatelus E, Sibilia J. Incidence and prevalence of systemic sclerosis: a systematic literature review. Semin Arthritis Rheum 2008;37: 223-35.
4. Tan FK. Systemic sclerosis: the susceptible host (genetics and environment). Rheum Dis Clin North Am 2003;29: 211-37.
5. Hassoun PM. Lung involvement in systemic sclerosis. Presse Med 2011;40:e3-17.
6. Jain S, Shahane A, Derk CT. Interstitial lung disease in systemic sclerosis: pathophysiology, current and new advances in therapy. Inflamm Allergy Drug Targets 2012; 11:266-77.
7. Shoenfeld Y, Gerli R, Doria A et al. Accelerated atherosclerosis in autoimmune rheumatic diseases. Circulation 2005;112:3337-47.
8. Hansson GK. Inflammatory mechanisms in atherosclerosis. J Thromb Haemost 2009;7(Suppl 1):328-31.
9. Cushman M, Tsai AW, White RH et al. Deep vein thrombosis and pulmonary embolism in two cohorts: the longitudinal investigation of thromboembolism etiology. Am J Med 2004;117:19-25.
10. Chung WS, Peng CL, Lin CL et al. Rheumatoid arthritis increases the risk of deep vein thrombosis and pulmonary thromboembolism: a nationwide cohort study. Ann Rheum Dis 2013, Aug 13. doi: 10.1136/annrheumdis-2013-203380 [Epub ahead of print].
11. Chung WS, Lin CL, Ho FM et al. Asthma increases pulmonary thromboembolism risk: a nationwide population cohort study. Eur Respir J 2013;43:801-7.
12. Zoller B, Li X, Sundquist J, Sundquist K. Risk of pulmonary embolism in patients with autoimmune disorders: a nationwide follow-up study from Sweden. Lancet 2012;379: 244-9.
13. Cheng TM. Taiwan's national health insurance system: high value for the dollar. In: Okma KGH, Crivelli L, eds. Six Countries, Six Reform Models: The Health Reform Experience of Israel, the Netherlands, New Zealand, Singapore, Switzerland and Taiwan. Hackensack, NJ, USA: World Scientific, 2009:71-204.
14. Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. Arthritis Rheum 1980;23:581-90.
15. Yu KH, See LC, Kuo CF, Chou IJ, Chou MJ. Prevalence and incidence in patients with autoimmune rheumatic diseases: a nationwide population-based study in Taiwan. Arthritis Care Res 2013;65:244-50.
16. Ramagopalan SV, Wotton CJ, Handel AE, Yeates D, Goldacre MJ. Risk of venous thromboembolism in people admitted to hospital with selected immune-mediated diseases: record-linkage study. BMC Med 2011;9:1.
17. Keenan CR, White RH. The effects of race/ethnicity and sex on the risk of venous thromboembolism. Curr Opin Pulm Med 2007;13:377-83.
18. White RH, Keenan CR. Effects of race and ethnicity on the incidence of venous thromboembolism. Thromb Res 2009;123(Suppl 4):S11-7.
19. McNearney TA, Reveille JD, Fischbach M et al. Pulmonary involvement in systemic sclerosis: associations with genetic, serologic, sociodemographic, and behavioral factors. Arthritis Rheum 2007;57:318-26.
20. Esmon CT. The interactions between inflammation and coagulation. Br J Haematol 2005;131:417-30.
21. Xu J, Lupu F, Esmon CT. Inflammation, innate immunity and blood coagulation. Hamostaseologie 2010; 30:5-6.
22. Dahlback B. Coagulation and inflammation-close allies in health and disease. Semin Immunopathol 2012; 34:1-3.
23. Murdaca G, Colombo BM, Cagnati P et al. Endothelial dysfunction in rheumatic autoimmune diseases. Atherosclerosis 2012;224:309-17.
24. Sitia S, Tomasoni L, Atzeni F et al. From endothelial dysfunction to atherosclerosis. Autoimmun Rev 2010;9: 830-4.
25. Kniffin WD Jr, Baron JA, Barrett J, Birkmeyer JD, Anderson FA Jr. The epidemiology of diagnosed pulmonary embolism and deep venous thrombosis in the elderly. Arch Intern Med 1994;154:861-6.
26. White RH. The epidemiology of venous thromboembolism. Circulation 2003;107:I4-8.
27. Engbers MJ, van Hylckama Vlieg A, Rosendaal FR. Venous thrombosis in the elderly: incidence, risk factors and risk groups. J Thromb Haemost 2010;8: 2105-12.
28. Cohen AT, Tapson VF, Bergmann JF et al. Venous thromboembolism risk and prophylaxis in the acute hospital care setting (ENDORSE study): a multinational cross-sectional study. Lancet 2008;371:387-94.
29. Anderson FA Jr, Zayaruzny M, Heit JA, Fidan D, Cohen AT. Estimated annual numbers of US acute-care hospital patients at risk for venous thromboembolism. Am J Hematol 2007;82:777-82.
30. Denton CP, Black CM. Pulmonary hypertension in systemic sclerosis. Rheum Dis Clin North Am 2003;29: 335-49.